Table 3 Unadjusted means, standard deviations, ranges, and effect sizes for within group tests (patient outcomes)
Baseline | Post-Intervention | 3-month follow-up | Baseline-post effect | Post-3-month effect | Baseline-3-month effect | |
|---|---|---|---|---|---|---|
M(SD), Range | M(SD), Range | M(SD), Range | Cohen’s D | Cohen’s D | Cohen’s D | |
Patient outcome | ||||||
Depression | ||||||
(HADS) RT | 4.00 (2.82), 1–8 | 2.71 (3.35), 0–8 | 3.00 (3.89), 0–10 | − .41 | .08 | − .29 |
MEUC | 6.31 (4.19), 1–14 | 10.11 (3.52), 4–16 | 8.63 (2.88), 5–12 | .98 | − .46 | .64 |
Anxiety | ||||||
(HADS) RT | 9.57 (4.89), 3–17 | 4.33 (3.27), 1–10 | 4.50 (2.59), 0–7 | − 1.25 | .06 | − 1.29 |
MEUC | 10.24 (4.89), 2–18 | 12.67 (5.94), 2–19 | 9.88 (6.47), 2–18 | .44 | − .45 | − .04 |
Post-traumatic stress | ||||||
(PCL-C) RT | 36.14 (16.54), 17–61 | 24.57 (10.61), 17–48 | 28.50 (11.42), 18–48 | − .83 | .36 | − .53 |
MEUC | 37.33 (7.81), 27-47 | 43.75 (10.61), 26–57 | 38.88 (11.82), 20–56 | .68 | − .43 | .15 |
Self-efficacy | ||||||
(GSE) RT | 32.57 (5.06), 26–39 | 34.71 (6.16), 23–40 | 33.67 (5.68), 26–40 | .38 | − .18 | .20 |
MEUC | 28.78 (6.48), 20–40 | 26.78 (5.85), 19–39 | 28.38 (6.30), 18–40 | − .32 | .26 | − .06 |
Coping skills | ||||||
(MOCS-A) RT | 30.60 (6.58), 19–35 | 37.67 (12.03), 17–52 | 37.40 (8.02), 27–49 | .72 | − .02 | .92 |
MEUC | 26.44 (9.06), 14–38 | 23.00 (11.75), 10–48 | 26.14 (12.88), 12–47 | − .32 | .25 | − .02 |
Mindfulness | ||||||
(CAMS) RT | 32.29 (4.11), 28–39 | 34.60 (9.97), 23–44 | 39.17 (6.77), 30–47 | .30 | .54 | 1.22 |
MEUC | 31.56 (5.27), 24–39 | 27.89 (8.74), 19–45 | 29.75 (11.77), 15–47 | − .51 | .18 | − .20 |
Relationship quality | ||||||
(IBM) RT | 37.57 (4.54), 31–45 | 44.17 (9.97), 36–60 | 39.00 (7.48), 31–53 | .85 | − .59 | .23 |
MEUC | 31.56 (5.27), 35–52 | 40.63 (10.56), 25–56 | 34.43 (8.00), 22–47 | 1.09 | − .66 | .42 |
Treatment credibility | ||||||
(CEQ) RT | 22.76 (7.42), 6–27 | N/A | N/A | N/A | N/A | N/A |
MEUC | 19.30 (4.59), 12.60–25.20 | N/A | N/A | N/A | N/A | N/A |
Treatment expectancy | ||||||
(CEQ) RT | 23.79 (8.38), 5.4–28.80 | N/A | N/A | N/A | N/A | N/A |
MEUC | 22.28(3.69), 15.30–26.10 | N/A | N/A | N/A | N/A | N/A |
Treatment satisfaction | ||||||
(CSQ-3) RT | N/A | 11.33 (1.03), 10–12 | N/A | N/A | N/A | N/A |
MEUC | N/A | 9.00 (2.31), 5–12 | N/A | N/A | N/A | N/A |
Caregiver outcome | ||||||
Depression | ||||||
(HADS) RT | 3.86 (3.72), 0–8 | 2.14 (1.07), 0–3 | 3.60 (2.19), 1–7 | − .63 | .85 | .09 |
MEUC | 3.56 (3.97), 0–11 | 6.25 (3.62), 0–11 | 6.17 (4.83), 1–13 | .71 | − .02 | − .59 |
Anxiety | ||||||
(HADS) RT | 10.14 (5.61), 3–19 | 6.83 (1.47), 5–8 | 7.80 (1.92), 5–10 | − .81 | .57 | .56 |
MEUC | 8.67 (4.90), 1–15 | 11.00 (4.72), 4–18 | 9.17 (3.55), 4–13 | .48 | − .32 | − .12 |
Post-traumatic stress | ||||||
(PCL-C) RT | 39.00 (19.05), 17–67 | 25.33 (5.43), 17–32 | 27.50 (7.74), 22–42 | − .98 | .32 | .79 |
MEUC | 30.78 (7.29), 21–41 | 35.86 (13.98), 23–59 | 38.00 (13.24), 23–53 | .46 | .22 | − .68 |
Self-efficacy | ||||||
(GSE) RT | 33.57 (2.51), 28–39 | 33.33 (4.18), 29–40 | 32.20 (4.60), 26–38 | − .07 | − .26 | − .37 |
MEUC | 32.88 (3.27), 29–38 | 30.22 (4.79), 22–37 | 30.67 (4.97), 22–37 | − .65 | .09 | − .53 |
Coping skills | ||||||
(MOCS-A) RT | 32.17 (16.24), 7–52 | 38.83 (7.68), 31–52 | 33.25 (5.38), 25–38 | .52 | − .55 | .09 |
MEUC | 32.13 (7.40), 21–41 | 24.38 (10.27), 8–39 | 27.33 (7.58), 18–40 | − .87 | .33 | − .64 |
Mindfulness | ||||||
(CAMS) RT | 36.00 (8.33), 23–45 | 40.33 (4.76), 34–48 | 37.00 (6.90), 26–46 | .64 | − .57 | .13 |
MEUC | 36.86 (5.37), 30–44 | 31.67 (7.58), 19–42 | 31.67 (5.50), 25–38 | − .79 | .00 | − .95 |
Relationship quality | ||||||
(IBM) RT | 39.58 (2.51), 35–42 | 38.67 (2.80), 36–43 | 39.40 (4.77), 34–47 | − .34 | .19 | − .04 |
MEUC | 40.50 (9.65), 31–61 | 36.75 (14.16), 16–58 | 36.00 (8.81), 25–48 | − .31 | − .01 | − .49 |
Treatment credibility | ||||||
(CEQ) RT | 22.68 (4.56), 17.10–27.00 | N/A | N/A | N/A | N/A | N/A |
MEUC | 20.10 (4.57), 11.70–27.00 | N/A | N/A | N/A | N/A | N/A |
Treatment expectancy | ||||||
(CEQ) RT | 21.90 (6.25), 11.70–28.80 | N/A | N/A | N/A | N/A | N/A |
MEUC | 24.60 (2.25), 21.60–27.00 | N/A | N/A | N/A | N/A | N/A |
Treatment satisfaction | ||||||
(CSQ-3) RT | N/A | 12.00 (0.00), 12–12 | N/A | N/A | N/A | N/A |
MEUC | N/A | 9.00 (1.73), 7–12 | N/A | N/A | N/A | N/A |